ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
프로프라놀롤 의약품 시장 규모는 향후 몇 년 동안 강력한 성장을 보일 것으로 예상됩니다. 예측 기간 동안의 성장은 비침습적 치료에 대한 수요 증가, 심혈관 의약품에 대한 연구 개발 증가, 신흥 경제국의 의료비 지출 증가, 심혈관 치료에 개인 맞춤형 의약품의 채택 증가와 같은 요인에 기인할 수 있습니다. 예측 기간 동안의 주요 동향으로는 지속 방출 제제의 발전, 첨단 약물 전달 시스템의 개발, 심혈관 치료를 위한 개인 맞춤형 의약품의 혁신, 디지털 건강 도구와 약물 요법의 통합, 불안 및 고혈압에 대한 복합 요법의 첨단 연구 등이 있습니다.
심혈관 질환(CVD)의 유병률 증가가 프로프라놀롤 의약품 시장의 확장을 촉진할 것으로 예상됩니다. CVD는 관상 동맥 질환, 심부전, 뇌졸중 등 심장과 혈관에 영향을 미치는 질환을 말합니다. 심혈관 질환의 증가는 주로 건강에 해로운 식습관으로 인해 발생하며, 가공 식품과 지방의 과도한 섭취는 콜레스테롤 수치를 상승시켜 심장 관련 질환의 위험을 높입니다. 프로프라놀롤은 심박수를 조절하고 혈압을 낮춤으로써 이러한 질환을 관리하는 데 효과적이며, 특히 고혈압 및 부정맥 환자에게 유용합니다. 또한 이 의약품은 심장 기능을 강화하여 심장 마비 및 뇌졸중의 위험을 줄여 전반적인 심혈관 건강을 개선합니다.
프로프라놀롤 의약품 시장의 주요 업체들은 환자의 치료 순응도와 전반적인 치료 결과를 개선하기 위해 서방형 프로프라놀롤 의약품과 같은 고급 제형 개발에 주력하고 있습니다. 서방형 제제는 의약품을 시간이 지남에 따라 서서히 방출하도록 설계되어, 지속적인 치료 효과를 보장하고 빈번한 투여의 필요성을 줄입니다. 이는 환자의 순응도를 향상시킬 뿐 아니라 치료 효과도 높입니다. 예를 들어, 2023년 8월, 캐나다에 본사를 둔 제약 회사인 Lupin Pharma Canada Ltd.는 Inderal long-acting (LA)의 단종에 대응하여 장시간 작용형 프로프라놀롤 캡슐을 출시했습니다. 새로운 서방형 제제는 60mg, 80mg, 120mg, 160mg 용량으로 제공되며, 캐나다 환자에게 일관된 증상 완화를 제공하여 복용 순응도를 개선하고 치료 결과를 향상시키며 의료 접근성을 높입니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 19 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 프로프라놀롤 의약품 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 프로프라놀롤 의약품 시장 : 성장률 분석
세계의 프로프라놀롤 의약품 시장 실적 : 규모와 성장(2019-2024년)
세계의 프로프라놀롤 의약품 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 프로프라놀롤 의약품 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 프로프라놀롤 의약품 시장 투여량별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
정제
주사액
서방형 캡슐
경구액
세계의 프로프라놀롤 의약품 시장 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
고혈압
협심증
편두통 예방
외상 후 스트레스 장애(PTSD)
본태성 진전
불안 장애의 치료 옵션
세계의 프로프라놀롤 의약품 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원
클리닉
재택 헬스케어 환경
간병 시설
제약회사
세계의 프로프라놀롤 의약품 시장 정제 유형별 세분화, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 프로프라놀롤 의약품 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 프로프라놀롤 의약품 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
프로프라놀롤 의약품 시장 : 경쟁 구도
프로프라놀롤 의약품 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Teva Pharmaceutical Industries Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Boehringer Ingelheim International GmbH : 개요, 제품 및 서비스, 전략 및 재무 분석
Sandoz Group AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi AG : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Cipla Limited
Hikma Pharmaceuticals PLC
Amneal Pharmaceuticals Inc.
Lupin Limited
Alkem Laboratories Ltd.
Torrent Pharmaceuticals Ltd.
Ipca Laboratories Limited
Mankind Pharma Ltd.
Lannett Company Inc.
Jubilant Pharma Holdings Inc.
Actiza Pharmaceutical Private Limited
Mylan Laboratories Inc.
Neurocon Inc.
Neuracle Lifesciences Pvt. Ltd.
Yabang Pharmaceutical Group Co. Ltd.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
프로프라놀롤 의약품 시장(2029년) : 새로운 기회를 제공하는 국가
프로프라놀롤 의약품 시장(2029년) : 새로운 기회를 제공하는 부문
프로프라놀롤 의약품 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Propranolol is a non-selective beta-blocker that reduces heart rate, blood pressure, cardiac workload, anxiety, and helps in migraine prevention. It works by blocking the effects of adrenaline on the heart and blood vessels, thereby lowering heart rate and blood pressure. Propranolol is also commonly prescribed to manage symptoms of anxiety, particularly performance anxiety.
The main forms of propranolol dosage include tablets, injectable solutions, extended-release capsules, and oral solutions. Propranolol tablets are solid oral medications containing propranolol hydrochloride, designed for rapid absorption to treat conditions such as high blood pressure, arrhythmias, and anxiety. They are typically taken multiple times a day with flexible dosing. Propranolol is used for a variety of indications, including hypertension, angina pectoris, migraine prevention, post-traumatic stress disorder (PTSD), essential tremors, and therapeutic options for anxiety disorders. It is employed by a range of end-users, including hospitals, clinics, home healthcare settings, nursing homes, and pharmaceutical companies.
The propranolol drug market research report is one of a series of new reports from The Business Research Company that provides propranolol drug market statistics, including the propranolol drug industry global market size, regional shares, competitors with the propranolol drug market share, detailed propranolol drug market segments, market trends, and opportunities, and any further data you may need to thrive in the propranolol drug industry. This propranolol drug market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The propranolol drug market size has grown strongly in recent years. It will grow from $1.05 billion in 2024 to $1.11 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to factors such as the rising incidence of migraine disorders, an increasing focus on affordable healthcare solutions, growing adoption of beta-blockers in post-surgery recovery, expanding healthcare infrastructure in developing regions, and a rising demand for long-acting drug formulations.
The propranolol drug market size is expected to see strong growth in the next few years. It will grow to $1.37 billion in 2029 at a compound annual growth rate (CAGR) of 5.5%. The growth during the forecast period can be attributed to factors such as the growing demand for non-invasive treatments, increasing research and development in cardiovascular drugs, rising healthcare spending in emerging economies, and the increasing adoption of personalized medicine in cardiovascular treatments. Key trends in the forecast period include advancements in sustained-release formulations, the development of advanced drug delivery systems, innovations in personalized medicine for cardiovascular treatments, the integration of digital health tools with drug therapy, and advanced research in combination therapies for anxiety and hypertension.
The rising prevalence of cardiovascular diseases (CVDs) is expected to drive the expansion of the propranolol drug market. CVDs are a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, and stroke. The increase in cardiovascular diseases is largely due to unhealthy eating habits, with excessive consumption of processed foods and fats leading to elevated cholesterol levels, which in turn raise the risk of heart-related issues. Propranolol is effective in managing these diseases by regulating heart rate and lowering blood pressure, making it particularly beneficial for patients with hypertension and arrhythmias. The drug also enhances heart function, reducing the risk of heart attacks and strokes, thus improving overall cardiovascular health. For example, in May 2024, the Centers for Disease Control and Prevention (CDC) reported that heart disease caused 702,880 deaths in 2022, accounting for one in every five deaths in the U.S. Additionally, around 805,000 people in the United States suffer a heart attack each year. Consequently, the growing prevalence of cardiovascular diseases is driving the demand for propranolol.
Key players in the propranolol drug market are focusing on developing advanced formulations, such as extended-release propranolol drugs, to improve patient adherence and overall therapeutic outcomes. Extended-release formulations are designed to gradually release the drug over time, ensuring sustained therapeutic effects and reducing the need for frequent dosing. This not only improves patient compliance but also enhances treatment effectiveness. For example, in August 2023, Lupin Pharma Canada Ltd., a pharmaceutical company based in Canada, launched long-acting propranolol capsules in response to the discontinuation of Inderal long-acting (LA). The new extended-release formulation, available in doses of 60 mg, 80 mg, 120 mg, and 160 mg, offers consistent symptom relief for Canadian patients, improving adherence and treatment outcomes, while increasing healthcare access.
In December 2024, Exicure Inc., a biotechnology company based in the U.S., entered into a partnership with GPCR Therapeutics Inc. This collaboration aims to bolster Exicure's position as a clinical-stage biotech company by acquiring technical expertise and gaining access to GPCR Therapeutics' proprietary CXCR4 inhibitor technology. This partnership enhances Exicure's drug development pipeline, particularly in the areas of immuno-oncology, fibrosis, and obesity treatments. GPCR Therapeutics Inc., based in South Korea, is also involved in the manufacturing of propranolol drugs.
Major players in the propranolol drug market are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Sandoz Group AG, Fresenius Kabi AG, Cipla Limited, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals Inc., Lupin Limited, Alkem Laboratories Ltd., Torrent Pharmaceuticals Ltd., Ipca Laboratories Limited, Mankind Pharma Ltd., Lannett Company Inc., Jubilant Pharma Holdings Inc., Actiza Pharmaceutical Private Limited, Mylan Laboratories Inc., Neurocon Inc., Neuracle Lifesciences Pvt. Ltd., Yabang Pharmaceutical Group Co. Ltd.
North America was the largest region in the propranolol drug market in 2024. The regions covered in propranolol drug report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the propranolol drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The propranolol drug market consists of sales of intravenous (IV) infusion. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Propranolol Drug Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on propranolol drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for propranolol drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The propranolol drug market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Propranolol Drug Market Characteristics
3. Propranolol Drug Market Trends And Strategies
4. Propranolol Drug Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Propranolol Drug Growth Analysis And Strategic Analysis Framework
5.1. Global Propranolol Drug PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Propranolol Drug Market Growth Rate Analysis
5.4. Global Propranolol Drug Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Propranolol Drug Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Propranolol Drug Total Addressable Market (TAM)
6. Propranolol Drug Market Segmentation
6.1. Global Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Tablets
Injectable Solutions
Extended-Release Capsules
Oral Solution
6.2. Global Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hypertension
Angina Pectoris
Migraine Prevention
Post-Traumatic Stress Disorder (PTSD)
Essential Tremors
Therapeutic Options In Anxiety Disorders
6.3. Global Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Clinics
Home Healthcare Settings
Nursing Homes
Pharmaceutical Companies
6.4. Global Propranolol Drug Market, Sub-Segmentation Of Tablets, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Standard Tablets
Chewable Tablets
Film-Coated Tablets
6.5. Global Propranolol Drug Market, Sub-Segmentation Of Injectable Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intravenous Solutions
Intramuscular Solutions
Pre-Filled Syringes
6.6. Global Propranolol Drug Market, Sub-Segmentation Of Extended-Release Capsules, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
60 Milligrams (mg)
80 Milligrams (mg)
120 Milligrams (mg)
160 Milligrams (mg)
6.7. Global Propranolol Drug Market, Sub-Segmentation Of Oral Solution, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Liquid Suspension
Concentrated Oral Solution
Ready-To-Use Oral Solution
7. Propranolol Drug Market Regional And Country Analysis
7.1. Global Propranolol Drug Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Propranolol Drug Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Propranolol Drug Market
8.1. Asia-Pacific Propranolol Drug Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Propranolol Drug Market
9.1. China Propranolol Drug Market Overview
9.2. China Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Propranolol Drug Market
10.1. India Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Propranolol Drug Market
11.1. Japan Propranolol Drug Market Overview
11.2. Japan Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Propranolol Drug Market
12.1. Australia Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Propranolol Drug Market
13.1. Indonesia Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Propranolol Drug Market
14.1. South Korea Propranolol Drug Market Overview
14.2. South Korea Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Propranolol Drug Market
15.1. Western Europe Propranolol Drug Market Overview
15.2. Western Europe Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Propranolol Drug Market
16.1. UK Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Propranolol Drug Market
17.1. Germany Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Propranolol Drug Market
18.1. France Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Propranolol Drug Market
19.1. Italy Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Propranolol Drug Market
20.1. Spain Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Propranolol Drug Market
21.1. Eastern Europe Propranolol Drug Market Overview
21.2. Eastern Europe Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Propranolol Drug Market
22.1. Russia Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Propranolol Drug Market
23.1. North America Propranolol Drug Market Overview
23.2. North America Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Propranolol Drug Market
24.1. USA Propranolol Drug Market Overview
24.2. USA Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Propranolol Drug Market
25.1. Canada Propranolol Drug Market Overview
25.2. Canada Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Propranolol Drug Market
26.1. South America Propranolol Drug Market Overview
26.2. South America Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Propranolol Drug Market
27.1. Brazil Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Propranolol Drug Market
28.1. Middle East Propranolol Drug Market Overview
28.2. Middle East Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Propranolol Drug Market
29.1. Africa Propranolol Drug Market Overview
29.2. Africa Propranolol Drug Market, Segmentation By Dosage, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Propranolol Drug Market, Segmentation By Indication-Based, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Propranolol Drug Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Propranolol Drug Market Competitive Landscape And Company Profiles
30.1. Propranolol Drug Market Competitive Landscape
30.2. Propranolol Drug Market Company Profiles
30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Teva Pharmaceutical Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Sandoz Group AG Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Fresenius Kabi AG Overview, Products and Services, Strategy and Financial Analysis
31. Propranolol Drug Market Other Major And Innovative Companies
31.1. Cipla Limited
31.2. Hikma Pharmaceuticals PLC
31.3. Amneal Pharmaceuticals Inc.
31.4. Lupin Limited
31.5. Alkem Laboratories Ltd.
31.6. Torrent Pharmaceuticals Ltd.
31.7. Ipca Laboratories Limited
31.8. Mankind Pharma Ltd.
31.9. Lannett Company Inc.
31.10. Jubilant Pharma Holdings Inc.
31.11. Actiza Pharmaceutical Private Limited
31.12. Mylan Laboratories Inc.
31.13. Neurocon Inc.
31.14. Neuracle Lifesciences Pvt. Ltd.
31.15. Yabang Pharmaceutical Group Co. Ltd.
32. Global Propranolol Drug Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Propranolol Drug Market
34. Recent Developments In The Propranolol Drug Market
35. Propranolol Drug Market High Potential Countries, Segments and Strategies
35.1 Propranolol Drug Market In 2029 - Countries Offering Most New Opportunities
35.2 Propranolol Drug Market In 2029 - Segments Offering Most New Opportunities
35.3 Propranolol Drug Market In 2029 - Growth Strategies
